Skip to content

HIV, Equity, and Addiction Training (HEAT) Program

HIV, Equity, and Addiction Training (HEAT) Program

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06370481
Acronym
HEAT
Enrollment
30
Registered
2024-04-17
Start date
2026-01-29
Completion date
2029-06-01
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv, Opioid Use Disorder, Stimulant Use (Diagnosis), Substance Use Disorders

Keywords

Alabama, Ryan White Clinics, HIV treatment, Substance use disorder treatment, Telemedicine

Brief summary

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

Detailed description

The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.

Interventions

OTHERTelemedicine

Routine care administered via telemedicine

OTHERStandard of care

Standard of care, as received in HIV clinic settings

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Receiving services at HIV clinics in Alabama * Reported opioid and/or stimulant misuse * 18 years of age or older

Exclusion criteria

* Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months * Inability to engage in interviews independently without support (e.g., cognitive impairment) * Currently psychotic * Actively suicidal: presents with a suicide attempt or suicidal ideation

Design outcomes

Primary

MeasureTime frameDescription
Percent of participants who have a follow-up healthcare visit1 month, 2 months, 3 monthsFollow up visit for care (either telemedicine or in person)

Countries

United States

Contacts

CONTACTEllen F Eaton, MD, MSPH
eeaton@uabmc.edu2059750661
CONTACTStephen Tyler O'Rear
storear@uabmc.edu2057214060
PRINCIPAL_INVESTIGATOREllen F Eaton, MD, MSPH

University of Alabama at Birmingham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026